These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35749302)

  • 1. Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers.
    Girard N; Basse C; Schrock A; Ramkissoon S; Killian K; Ross JS
    Oncologist; 2022 Nov; 27(11):919-929. PubMed ID: 35749302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic characterization of thymic epithelial tumors in a real-world dataset.
    Kurokawa K; Shukuya T; Greenstein RA; Kaplan BG; Wakelee H; Ross JS; Miura K; Furuta K; Kato S; Suh J; Sivakumar S; Sokol ES; Carbone DP; Takahashi K
    ESMO Open; 2023 Oct; 8(5):101627. PubMed ID: 37703595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.
    Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L
    Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.
    Girard N; Shen R; Guo T; Zakowski MF; Heguy A; Riely GJ; Huang J; Lau C; Lash AE; Ladanyi M; Viale A; Antonescu CR; Travis WD; Rusch VW; Kris MG; Pao W
    Clin Cancer Res; 2009 Nov; 15(22):6790-9. PubMed ID: 19861435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatment of advanced thymic malignancies.
    Kelly RJ
    Am Soc Clin Oncol Educ Book; 2014; ():e367-73. PubMed ID: 24857125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
    Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
    Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular landscape of thymic epithelial tumors.
    Prays J; Ortiz-Villalón C
    Semin Diagn Pathol; 2022 Mar; 39(2):131-136. PubMed ID: 34272124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic characterization of thymic epithelial tumors reveals critical genes underlying tumorigenesis and poor prognosis.
    Tan S; Chen J; Wang Z; Zhao X; Sun Y; Zhu Y; Gong Z; Zhang D
    Clin Genet; 2023 May; 103(5):529-539. PubMed ID: 36541162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosis.
    Moreira AL; Won HH; McMillan R; Huang J; Riely GJ; Ladanyi M; Berger MF
    J Thorac Oncol; 2015 Feb; 10(2):373-80. PubMed ID: 25299233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions.
    Vivero M; Davineni P; Nardi V; Chan JKC; Sholl LM
    Mod Pathol; 2020 Apr; 33(4):560-565. PubMed ID: 31641231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations.
    Ross JS; Wang K; Khaira D; Ali SM; Fisher HA; Mian B; Nazeer T; Elvin JA; Palma N; Yelensky R; Lipson D; Miller VA; Stephens PJ; Subbiah V; Pal SK
    Cancer; 2016 Mar; 122(5):702-11. PubMed ID: 26651075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequent BAP1, PIK3CA, and other actionable genomic alterations.
    Wang K; McDermott JD; Schrock AB; Elvin JA; Gay L; Karam SD; Raben D; Somerset H; Ali SM; Ross JS; Bowles DW
    Ann Oncol; 2017 Apr; 28(4):748-753. PubMed ID: 28327999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.
    Pal SK; Ali SM; Yakirevich E; Geynisman DM; Karam JA; Elvin JA; Frampton GM; Huang X; Lin DI; Rosenzweig M; Lipson D; Stephens PJ; Ross JS; Miller VA; Agarwal N; Shuch B; Choueiri TK; Chung JH
    Eur Urol; 2018 Jan; 73(1):71-78. PubMed ID: 28592388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.
    Ardeshir-Larijani F; Schneider BP; Althouse SK; Radovich M; Masood A; Perna F; Salman H; Loehrer PJ
    JCO Precis Oncol; 2023 Feb; 7():e2200465. PubMed ID: 36787505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies.
    Lococo F; De Paolis E; Evangelista J; Dell'Amore A; Giannarelli D; Chiappetta M; Campanella A; Sassorossi C; Cancellieri A; Calabrese F; Conca A; Vita E; Minucci A; Bria E; Castello A; Urbani A; Rea F; Margaritora S; Scambia G
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoma versus thymic carcinoma: differences in biology impacting treatment.
    Kelly RJ
    J Natl Compr Canc Netw; 2013 May; 11(5):577-83. PubMed ID: 23667207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Integrated Genomic Landscape of Thymic Epithelial Tumors.
    Radovich M; Pickering CR; Felau I; Ha G; Zhang H; Jo H; Hoadley KA; Anur P; Zhang J; McLellan M; Bowlby R; Matthew T; Danilova L; Hegde AM; Kim J; Leiserson MDM; Sethi G; Lu C; Ryan M; Su X; Cherniack AD; Robertson G; Akbani R; Spellman P; Weinstein JN; Hayes DN; Raphael B; Lichtenberg T; Leraas K; Zenklusen JC; ; Fujimoto J; Scapulatempo-Neto C; Moreira AL; Hwang D; Huang J; Marino M; Korst R; Giaccone G; Gokmen-Polar Y; Badve S; Rajan A; Ströbel P; Girard N; Tsao MS; Marx A; Tsao AS; Loehrer PJ
    Cancer Cell; 2018 Feb; 33(2):244-258.e10. PubMed ID: 29438696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes.
    Yang J; Zhang B; Guan W; Fan Z; Pu X; Zhao L; Jiang W; Cai W; Quan X; Miao S; Nie L; He L
    Cancer Med; 2023 May; 12(9):10575-10586. PubMed ID: 36916520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and mutational status of c-kit in thymic epithelial tumors.
    Petrini I; Zucali PA; Lee HS; Pineda MA; Meltzer PS; Walter-Rodriguez B; Roncalli M; Santoro A; Wang Y; Giaccone G
    J Thorac Oncol; 2010 Sep; 5(9):1447-53. PubMed ID: 20651610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic tumors: relevant molecular data in the clinic.
    Girard N
    J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S291-5. PubMed ID: 20859122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.